Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Connexin 43 - Zonula occludens-1 interaction constitutes a critical regulatory interface for gap junction formation, size, and cell-cell communication. Connexin 43 (Cx43) forms intercellular channels that assemble into gap junctions, crucial for ionic and molecular exchange in tissues. Zonula occludens-1 (ZO-1), a scaffold tight junction protein, binds specifically to the carboxy terminus of Cx43 via a PDZ domain interaction, mostly at the periphery of gap junction plaques. This interaction controls the recruitment and turnover of connexons (hemichannels) into gap junctions; when ZO-1 binding to Cx43 is inhibited, gap junctions enlarge, increasing intercellular coupling but altering cellular permeability and organization. Regulation of this interface is important in excitable tissues such as the heart and brain, influencing disease states when dysregulated[1][2][3][4].
Disruption of Cx43-ZO-1 binding increases gap junction plaque size and enhances intercellular communication, while decreasing hemichannel activity in contacting cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Connexin 43 - Zonula occludens-1 interaction (null).